Search by Drug Name or NDC

    NDC 00069-0274-30 Velsipity 2 mg/1 Details

    Velsipity 2 mg/1

    Velsipity is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is ETRASIMOD ARGININE.

    Product Information

    NDC 00069-0274
    Product ID 0069-0274_d51313c5-d0f7-4324-830e-2a9ba2f48d4d
    Associated GPIs
    GCN Sequence Number 085399
    GCN Sequence Number Description etrasimod arginine TABLET 2 MG ORAL
    HIC3 Z11
    HIC3 Description SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATOR
    GCN 54865
    HICL Sequence Number 049267
    HICL Sequence Number Description ETRASIMOD ARGININE
    Brand/Generic Brand
    Proprietary Name Velsipity
    Proprietary Name Suffix n/a
    Non-Proprietary Name etrasimod
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name ETRASIMOD ARGININE
    Labeler Name Pfizer Laboratories Div Pfizer Inc
    Pharmaceutical Class Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA216956
    Listing Certified Through 2024-12-31

    Package

    NDC 00069-0274-30 (00069027430)

    NDC Package Code 0069-0274-30
    Billing NDC 00069027430
    Package 1 BOTTLE in 1 CARTON (0069-0274-30) / 30 TABLET, FILM COATED in 1 BOTTLE
    Marketing Start Date 2023-10-19
    NDC Exclude Flag N
    Pricing Information N/A